CPH
Click for more information
0.00% 0.9¢ creso pharma limited

Ann: Halucenex Secures Additional Pharmaceutical Grade Psilocybin, page-106

  1. getbig
    914 Posts.
    lightbulb Created with Sketch. 394
    clock Created with Sketch.
    19/05/21
    11:41
    Post #: 53272978
    Indeed. I wonder though, with the P2 and P3 trials in Canada - can this data and the findings also be used to support TGA approval in Australia? Or would CPH need to conduct its own local trials to support use of psilocybin as a therapy here?
    CPH Price at posting: 17.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

I88 Infini Resources logs two new uranium targets at Des Herbiers
right-arrow Created with Sketch.
SS1 Drill, drill, drill: 3 explorers with news on Friday – Sun Silver, Aurelia & PNX Metals
right-arrow Created with Sketch.
AUQ Alara Resources all set for second copper shipment from Oman
right-arrow Created with Sketch.
RAC Race delivers promising results in cancer drug mice research into heart complications
right-arrow Created with Sketch.
INF Infinity Lithium on the brink of full approval for San Jose project in Extremadura, Spain
right-arrow Created with Sketch.
SIG Sigma Healthcare shares drop as ACCC waves red flag over Chemist Warehouse ASX listing
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.